BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 2 filers reported holding BRIDGEBIO PHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,370 | -78.5% | 1,986 | -86.0% | 0.00% | -75.0% |
| Q2 2023 | $243,534 | +338141.7% | 14,159 | +222.7% | 0.01% | +300.0% |
| Q1 2023 | $72 | +44.0% | 4,388 | -32.3% | 0.00% | 0.0% |
| Q4 2022 | $50 | -100.0% | 6,484 | -61.4% | 0.00% | -33.3% |
| Q3 2022 | $167,000 | -44.0% | 16,795 | -48.8% | 0.00% | -57.1% |
| Q2 2022 | $298,000 | +66.5% | 32,813 | +86.8% | 0.01% | +250.0% |
| Q1 2022 | $179,000 | -34.9% | 17,566 | +6.4% | 0.00% | -60.0% |
| Q4 2021 | $275,000 | -50.4% | 16,516 | +39.6% | 0.01% | -64.3% |
| Q3 2021 | $554,000 | +69.9% | 11,832 | +121.3% | 0.01% | +75.0% |
| Q2 2021 | $326,000 | -30.2% | 5,347 | -29.4% | 0.01% | 0.0% |
| Q1 2021 | $467,000 | +165.3% | 7,579 | +206.3% | 0.01% | +60.0% |
| Q4 2020 | $176,000 | +38.6% | 2,474 | -26.6% | 0.01% | +400.0% |
| Q3 2020 | $127,000 | -83.6% | 3,371 | -85.8% | 0.00% | -96.9% |
| Q2 2020 | $775,000 | +1939.5% | 23,776 | +2067.4% | 0.03% | +966.7% |
| Q4 2019 | $38,000 | +280.0% | 1,097 | +136.9% | 0.00% | +200.0% |
| Q3 2019 | $10,000 | – | 463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,835,722 | $82,353,000 | 42.93% |
| Kohlberg Kravis Roberts & Co. L.P. | 36,900,661 | $792,257,000 | 4.46% |
| Perceptive Advisors | 6,706,268 | $143,983,000 | 3.88% |
| Cormorant Asset Management, LP | 2,617,566 | $56,199,000 | 3.42% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $571,553,000 | 2.98% |
| SC US (TTGP), LTD. | 2,544,738 | $54,636,000 | 2.42% |
| HHLR ADVISORS, LTD. | 4,388,690 | $94,225,000 | 1.30% |
| Fernwood Investment Management, LLC | 95,200 | $2,044,000 | 1.01% |
| AMERICAN INTERNATIONAL GROUP, INC. | 6,746,511 | $144,847,000 | 0.58% |
| Ratan Capital Management LP | 46,548 | $999,000 | 0.53% |